{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T14:51:30Z","timestamp":1698504690146},"reference-count":0,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":1334,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[1998,5]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>No clinical study has been performed to\u2010date to evaluate the efficacy of the dual therapy of ranitidine bismuth citrate (RBC) plus clarithromycin (C) 500\u2003mg b.d. given for 7\u2003days for the eradication of <jats:italic>H. pylori<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim:<\/jats:title><jats:p>To assess the eradication rates achieved by treatment with RBC 400\u2003mg b.d. for 28\u2003days combined with clarithromycin 500\u2003mg b.d. for 7\u2003days in <jats:italic>H. pylori<\/jats:italic>\u2010positive duodenal ulcer patients. <jats:italic>Methods<\/jats:italic>: One hundred and twelve <jats:italic>H. pylori<\/jats:italic>\u2010positive patients with endoscopically proven active duodenal ulcer were included in a multicentre, open, randomized trial. <jats:italic>H. pylori<\/jats:italic> infection was initially detected by CLO\u2010test and histology on antral and corpus biopsies, and by <jats:sup>13<\/jats:sup>C\u2010urea breath test (UBT). Patients were included if at least two of the tests were positive for <jats:italic>H. pylori<\/jats:italic> infection. Patients were randomized to receive RBC 400\u2003mg b.d. for 4\u2003weeks combined with clarithromycin 500\u2003mg b.d. for the first 7\u2003days (Group A) or 14\u2003days (Group B). A second endoscopy was performed at least 28\u2003days after the end of therapy for the assessment of ulcer healing and <jats:italic>H. pylori<\/jats:italic> infection. Eradication was assumed if all the tests (CLO\u2010test, histology and UBT) were negative for <jats:italic>H. pylori<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Fifty patients in Group A and 55 in Group B were assessed for <jats:italic>H. pylori<\/jats:italic> eradication and ulcer healing. The eradication rates according to intention\u2010to\u2010treat analysis were 75% in Group A and 80% in Group B. Considering only those patients with evaluable data at least 28\u2003days after the end of therapy, <jats:italic>H. pylori<\/jats:italic> eradication was achieved in 84% and 82% in Group A and B, respectively. No statistically significant difference in eradication was found between the two groups by Mantel\u2013Haenszel test. Only one patient, in Group A, was withdrawn because of adverse events (epigastric pain and pruritus).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>Dual therapy with RBC plus clarithromycin for 7\u2003days could be an effective regimen for <jats:italic>H. pylori<\/jats:italic> eradication.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.1998.00334.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:36:32Z","timestamp":1047353792000},"page":"447-451","source":"Crossref","is-referenced-by-count":9,"title":["Ranitidine bismuth citrate plus clarithromycin 7\u2010day regimen is effective in eradicating <i>Helicobacter pylori<\/i> in patients with duodenal ulcer"],"prefix":"10.1111","volume":"12","author":[{"family":"Pozzato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Zagari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Cardelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Catalano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Giglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Lami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Pilotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Scarpulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Spadaccini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Susi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Tosatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Bazzoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Roda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1998.00334.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1998.00334.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.1998.00334.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T06:34:09Z","timestamp":1694414049000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.1998.00334.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,5]]}},"alternative-id":["10.1046\/j.1365-2036.1998.00334.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.1998.00334.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,5]]}}}